文献速递胸部CT

胸部CT在法国诊断COVID-19肺炎的效能

Efficacy of Chest CT for COVID-19 Pneumonia Diagnosis in France.
PubMed 文献 · Radiology · 2020-09-01

法国26家医院放射科于2020年3月2日至4月24日前瞻性纳入4824例同时行胸部CT和RT-PCR的可疑COVID-19肺炎患者,以出院诊断为参考标准,胸部CT诊断COVID-19的敏感度90%、特异度91%、阴性预测值89%、阳性预测值92%,26个不同地区站点间效能无显著差异。

要点

  • 胸部CT诊断COVID-19的敏感度90%(2319/2564,95%CI 89-91),特异度91%(2056/2260,95%CI 91-92)。
  • 胸部CT阴性预测值89%(2056/2300,95%CI 87-90),阳性预测值92%(2319/2524,95%CI 91-93)。
  • 26个地理区域站点间胸部CT效能无显著差异,各站点疾病流行率不同。

核心结论

  • 使用胸部CT对疑似COVID-19患者进行初始诊断和分诊是成功的。

研究设计与样本

  • 法国26家医院放射科参与的结构化CT扫描调查(NCT04339686),数据前瞻性收集并每周汇总。
  • 调查时间为2020年3月2日至2020年4月24日,对应法国COVID-19疫情高峰。
  • 纳入所有临床疑似COVID-19肺炎且接受初始胸部CT和48小时内至少一次RT-PCR检测的症状性患者。
  • 最终纳入4824例患者(平均年龄64岁±19岁,2669例男性),以基于多参数项目的出院诊断为参考标准。

诊断标准与关键数值

  • 以出院诊断为参考标准,胸部CT诊断COVID-19的敏感度为90%(2319/2564,95%CI 89-91)。
  • 胸部CT诊断COVID-19的特异度为91%(2056/2260,95%CI 91-92)。
  • 胸部CT诊断COVID-19的阴性预测值为89%(2056/2300,95%CI 87-90)。
  • 胸部CT诊断COVID-19的阳性预测值为92%(2319/2524,95%CI 91-93)。
  • 4824例中2564例最终诊断为COVID-19(53%)。

局限性

  • 7500例入组患者中2652例因无RT-PCR结果或RT-PCR与CT间隔未知或过长而被排除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The role and performance of chest CT in the diagnosis of the coronavirus disease 2019 (COVID-19) pandemic remains under active investigation. Purpose To evaluate the French national experience using chest CT for COVID-19, results of chest CT and reverse transcription polymerase chain reaction (RT-PCR) assays were compared together and with the final discharge diagnosis used as the reference standard. Materials and Methods A structured CT scan survey (NCT04339686) was sent to 26 hospital radiology departments in France between March 2, 2020, and April 24, 2020. These dates correspond to the peak of the national COVID-19 epidemic. Radiology departments were selected to reflect the estimated geographic prevalence heterogeneities of the epidemic. All symptomatic patients suspected of having COVID-19 pneumonia who underwent both initial chest CT and at least one RT-PCR test within 48 hours were included. The final discharge diagnosis, based on multiparametric items, was recorded. Data for each center were prospectively collected and gathered each week. Test efficacy was determined by using the Mann-Whitney test, Student t test, χ2 test, and Pearson correlation coefficient. P < .05 indicated a significant difference. Results Twenty-six of 26 hospital radiology departments responded to the survey, with 7500 patients entered; 2652 did not have RT-PCR test results or had unknown or excess delay between the RT-PCR test and CT. After exclusions, 4824 patients (mean age, 64 years ± 19 [standard deviation], 2669 male) were included. With final diagnosis as the reference, 2564 of the 4824 patients had COVID-19 (53%). Sensitivity, specificity, negative predictive value, and positive predictive value of chest CT in the diagnosis of COVID-19 were 2319 of 2564 (90%; 95% CI: 89, 91), 2056 of 2260 (91%; 95% CI: 91, 92), 2056 of 2300 (89%; 95% CI: 87, 90), and 2319 of 2524 (92%; 95% CI: 91, 93), respectively. There was no significant difference for chest CT efficacy among the 26 geographically separate sites, each with varying amounts of disease prevalence. Conclusion Use of chest CT for the initial diagnosis and triage of patients suspected of having coronavirus disease 2019 was successful. © RSNA, 2021 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Herpe G, Lederlin M, Naudin M, et al. Efficacy of Chest CT for COVID-19 Pneumonia Diagnosis in France. Radiology. 2020. PMID: 32870139. doi:10.1148/radiol.2020202568

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。